Related references
Note: Only part of the references are listed.A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy
Hyung Shik Kim et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
Danping Zhuang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma
Qiangqiang Zhao et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Photocrosslinked Bioreducible Polymeric Nanoparticles for Enhanced Systemic siRNA Delivery as Cancer Therapy
Johan Karlsson et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
A tumor-activatable peptide supramolecular nanoplatform for the delivery of dual-gene targeted siRNAs for drug-resistant cancer treatment
Yahui Wu et al.
NANOSCALE (2021)
siRNA Nanoparticle Suppresses Drug-Resistant Gene and Prolongs Survival in an Orthotopic Glioblastoma Xenograft Mouse Model
Kui Wang et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Camouflaging Nanoparticles with Brain Metastatic Tumor Cell Membranes: A New Strategy to Traverse Blood-Brain Barrier for Imaging and Therapy of Brain Tumors
Caixia Wang et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo
Petro Zhupanyn et al.
JOURNAL OF CONTROLLED RELEASE (2020)
O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth
Hao Nie et al.
NATURE COMMUNICATIONS (2020)
Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment
Yan Zou et al.
ADVANCED MATERIALS (2020)
Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy
Qi Fu et al.
LIFE SCIENCES (2020)
Recent advances in siRNA delivery mediated by lipid-based nanoparticles
Sei Yonezawa et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Sustained inhibition of PARP-1 activity delays glioblastoma recurrence by enhancing radiation-induced senescence
Atanu Ghorai et al.
CANCER LETTERS (2020)
The current state and future directions of RNAi-based therapeutics
Ryan L. Setten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Nanocarriers for Protein Delivery to the Cytosol: Assessing the Endosomal Escape of Poly(Lactide-co-Glycolide)-Poly(Ethylene Imine) Nanoparticles
Marianna Galliani et al.
NANOMATERIALS (2019)
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Bryan G. Allen et al.
CLINICAL CANCER RESEARCH (2019)
Cancer Cell Membrane-Camouflaged Nanorods with Endoplasmic Reticulum Targeting for Improved Antitumor Therapy
Wei Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours
Johan Karlsson et al.
NANOSCALE (2019)
Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression
Fengmei Pi et al.
NATURE NANOTECHNOLOGY (2018)
Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype
Jian Teng et al.
NEURO-ONCOLOGY (2018)
Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis
Yajuan Zhang et al.
MOLECULAR CELL (2018)
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient- derived xenografts with acquired temozolomide resistance
David S. Hersh et al.
NEURO-ONCOLOGY (2018)
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Xiaoyue Chen et al.
NATURE COMMUNICATIONS (2018)
Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy
Lei Hua et al.
THERANOSTICS (2018)
RNA interference-based therapy and its delivery systems
Xiuhui Chen et al.
CANCER AND METASTASIS REVIEWS (2018)
Acetylation of PGK1 Promotes Liver Cancer Cell Proliferation and Tumorigenesis
Hongli Hu et al.
HEPATOLOGY (2017)
RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials
Eunice L. Lozada-Delgado et al.
LIFE SCIENCES (2017)
Challenges and opportunities for siRNA-based cancer treatment
Tao Wang et al.
CANCER LETTERS (2017)
Cancer Cell Membrane-Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy
Ze Chen et al.
ACS NANO (2016)
Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors
Huiping Sun et al.
ADVANCED MATERIALS (2016)
Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis
Xinjian Li et al.
MOLECULAR CELL (2016)
Downregulation of phosphoglycerate kinase 1 by shRNA sensitizes U251 xenografts to radiotherapy
Yi-Jun Cheng et al.
ONCOLOGY REPORTS (2014)
Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines
Joshua C. Anderson et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Over-Expression of Cofilin-1 and Phosphoglycerate Kinase 1 in Astrocytomas Involved in Pathogenesis of Radioresistance
Hua Yan et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma
TL Hwang et al.
PROTEOMICS (2006)
Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer
DH Zhang et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Share Paper
